Why Buy-and-Bill, White Bagging, and Brown Bagging Each Demand a Different Playbook From a Specialty Pharmacy Billing Company 

There is little likelihood that specialty drugs will travel down a straightforward “prescribe-dispense-pay” track. With high-cost biologic products, cold chain logistics, and payer rules that can change throughout the year, the distribution model directly affects benefit verification, authorization, acquisition, claim submission, and payment. Whether the drug follows a buy-and-bill, white-bagging, or brown-bagging model it will effectively rewrite how payment occurs in its entirety. When it comes to predictably managing revenue, this is no longer a choice.

It is the difference between a clean reimbursement cycle and months of chasing denied claims. This is exactly where a specialty pharmacy billing company earns its keep, translating three very different operational realities into one coherent, compliant billing process.

Buy-and-Bill: The Traditional Model With a Cash-Flow Catch

Under buy-and-bill, the provider purchases the drug outright, stores it, administers it, and then bills the payer’s medical benefit for both the product and the administration services. It is the oldest and still the most common channel for provider-administered specialty drugs, largely because providers retain control over inventory, timing, and clinical workflow.

Despite growing pressure from white and clear bagging arrangements, buy-and-bill remains the dominant channel for provider-administered oncology drugs because provider pushback has limited how much share specialty pharmacies have been able to take.

The catch is financial exposure:

• As a provider, there is a need to pay for the medication upfront and at a cost which is quite hefty on each dosage administered, without seeing any form of reimbursement till long after the payment is made.
• In the event the claim is denied due to an error in coding, prior authorization not done or lack of benefits verification, then this is a liability of the provider alone.
• Manufacturer rebates add another reconciliation layer. In the year 2023, roughly one-third of employers and two-thirds of commercial health plans reported receiving rebates tied to provider-administered injectable and infused drugs. And that must be tracked separately from the claim itself. This is because it often leads to underpayment issues, 340B inventory tracking errors, and even audit and documentation risks.

An expert specialty pharmacy billing company understands these shortcomings well.

White Bagging: Rebate-Friendly for Payers, Complicated for Everyone Else

White bagging routes the drug mostly through a payer-affiliated specialty pharmacy, which ships it directly to the physician’s office or hospital for administration to a specific, named patient. The financial logic is straightforward. White bagging shifts coverage from the medical benefit to the pharmacy benefit, which typically opens up greater access to manufacturer rebates, letting payers streamline distribution and negotiate better terms with manufacturers.

The tradeoff shows up in billing complexity, and adoption varies sharply by therapy type and site of care. A 2020 survey data from 48 commercial health plans covering 127 million lives found:

• White bagging accounted for 11% of oncology sourcing at physician-affiliated clinics, versus 28% at hospital outpatient departments.
• For non-oncology products, the share climbed to 43% at clinics and 31% at hospital outpatient sites.

The correct channel is not fixed. It depends on the specific drug and where it is being administered. An expert specialty pharmacy billing company determines this correctly for every claim, because submitting a claim to the wrong benefit (medical vs. pharmacy) is one of the fastest ways to trigger a denial.

Brown Bagging: The Model With the Most Billing Risk

Brown bagging pushes the model one step further. The specialty pharmacy delivers the medication directly to the patient, who then transports it to the provider’s office for administration. In both white and brown bagging arrangements, the medication is billed to the patient’s pharmacy insurance plan rather than the medical benefit.

This is where billing workflows get genuinely fragile:

• Cold-chain integrity depends on the patient handling storage and transport correctly.
• Dosing verification happens outside a controlled pharmacy environment.
• A medication that is damaged, expired, or simply missing when it is needed for treatment will cause problems with scheduling and subsequent claims.
• The physician or health care provider may be hesitant about administering any drug that he or she has not ordered, because it complicates issues of liability.

The Hidden Costs That Cut Across All Three Models

Regardless of which model applies, a few billing headaches show up repeatedly:

• Benefit misclassification: Billing a white-bagged drug under the medical benefit, or a buy-and-bill drug under the pharmacy benefit, is one of the most common and most preventable denial triggers in specialty billing.
• Copay accumulator programs: As white bagging shifts more specialty drugs onto the pharmacy benefit, patients increasingly run into copay accumulator and maximizer programs. These do not count manufacturer assistance toward their deductible, creating downstream billing disputes and delayed patient collections.
• Site-of-care changes: In case a patient shifts from hospital infusion to home infusion or from a buy-and-bill process to white bag during treatment, the whole reimbursement procedure needs to be re-started. Simply put, new authorizations need to be received, new NDC to HCPCS mapping needs to be done.
• Timing disparities: The buy-and-bill billing process is completed after the medication administration but white and brown bagging are done before the medication administration is done. This becomes particularly complicated in case the dose is not administered or there are changes in dosage.

Read More:

How a Specialty Pharmacy Billing Company Increases Revenue

Why the Workflow Needs a Specialty Pharmacy Billing Company, Not Just Software

All of the above cannot be effectively managed by just any typical claims scrubbing engine or ready-made EHR billing module. Every distribution approach can have its own prior authorization process, its own benefit verification process, and its own denial management strategy. A specialty pharmacy billing company brings the payer-specific knowledge needed to:

• Verify which benefit applies before the drug even ships.
• Identify patient cost-sharing and copay-assistance issues that may affect pharmacy-benefit claims.
• Catch NDC or HCPCS mismatches before they turn into denials.
• Manage prior authorization renewals so approvals do not lapse mid-therapy; a common and costly failure point when billing is handled in-house alongside clinical operations.

SunKnowledge: Turning Billing Complexity Into Predictable Revenue

SunKnowledge has spent almost two decades supporting the billing operations of specialty pharmacies, hospitals, and clinics. We have worked across more than 28 specialties to keep claims moving cleanly through buy-and-bill, white bagging, and brown bagging workflows alike.

Rather than treating each distribution model as a separate problem, we build a single, coordinated process around benefit verification, prior authorization tracking, coding accuracy, and denial resolution, the exact points where specialty pharmacy billing tends to break down.

The results show up in KPIs clients can measure:

• Up to 80% reduction in operational costs.
• Low first-pass denial rates through accurate benefit and coding verification.
• Faster reimbursement turnaround across all three billing models.
• Dedicated account management that keeps prior authorizations and accumulator tracking from slipping through the cracks.

We function as a genuine extension of the billing team rather than a distant vendor. This is why practices lean on the partnership specifically when the distribution model and the payer rules around it keeps shifting underneath them.

For any specialty pharmacy, clinic, or hospital navigating the growing complexity of buy-and-bill, white bagging, and brown bagging, working with an experienced specialty pharmacy billing company like SunKnowledge is not just about outsourcing paperwork. It is about protecting revenue at every point where these models create risk.

Reach out to us for a free trial and a no-commitment consultation to see how a specialty pharmacy billing company built around these exact challenges can tighten the billing workflow and get more claims paid correctly the first time.